NICE Guidelines

 

KardiaMobile for detecting atrial fibrillation - January 2022
NICE guideline (NG197) – Shared decision making: Key recommendations for healthcare professionals
NICE guideline - Shared decision-making (NG197) - June 2021
NICE AF guideline (NG196) - Key recommendations for primary care NICE AF guideline (NG196) - Key recommendations for secondary care NICE AF guideline (NG196) - Key recommendations for tertiary and specialist care
Atrial fibrillation: Diagnosis and management - April 2021 Please note that NICE have amended the recommendation in the Atrial fibrillation guideline on using the ORBIT score to assess bleeding risk so that it links to a calculation tool that includes the full list of criteria, including reduced haemoglobin, reduced haematocrit and history of anaemia. The recommendation previously contained a link to a tool which didn’t include the full criteria.
Chronic heart failure in adults: diagnosis and management - September 2018
Chronic heart failure in adults - September 2018
Chronic Heart Failure: Management of chronic heart failure in adults in primary and secondary care (update) - March 2018
Surveillance report 2017 – Atrial fifibrillation: management (2014) NICE guideline CG180
New indicators to be added to the NICE indicator menu for general practice - August 2017
New indicators to be added to the NICE indicator menu for clinical commissioning groups -August 2017
Pulse rhythm assessment and annual review for people with AF - June 2017
Guide to the technology appraisal and highly specialised technologies appeal process- April 2017
AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fifibrillation
NICE Atrial Fibrillation Quality Standard- July 2015
NICE Atrial Fribrillation: QS93- July 2015
NICE publish update on AF management: CG180- June 2014

NICE Guidelines- Anticoagulants

 

Edoxaban for preventing stroke and systemic embolism in people with nonvalvularatrial fifibrillation- September 2015
Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fifibrillation- February 2013
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fifibrillation- May 2012
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fifibrillation- March 2012

November 2014: NICE value the contribution that members of the public make to their guidance and quality standards

If you would like to consider becoming a representative, please view the current opportunities.

View opportunities

 

October 2014: NICE issues correction for anticoagulant and antidepressant drug interaction recommendations

Specifically, a correction was made to the table of drug interactions in Appendix 16, page 366. For conditions requiring anticoagulation, mirtazapine has been moved from the ‘Antidepressants to avoid or use with caution’ column to the ‘Antidepressants recommended’ column.

Read more

 

24 September 2014: Nice issues guidance on self-monitoring for people on long-term warfarin therapy

The National Institute for Health and Care Excellence releases diagnostics guidance on two new devices to support self-testing for NHS use.

Read AF Association's response
Read guidance on the NICE website
Download diagnostics guidance
Post a 'selfie' and join the Facebook self-monitoring community

 

NICE Implementation Collaborative: Consensus: Supporting local implementation of NICE guidance on use of the novel (non-Vitamin K antagonist) oral anticoagulants in non-valvular atrial fibrillation.

View report on NICE website

Read our Press Release

 

AF Association welcomes NICE clinical guideline on management of AF

15 June 2014, Sky News
Charity Founder and CEO, Trudie Lobban MBE, backs new guidelines that will assess the role of aspirin in the management of AF-related stroke. Watch now

ESC Guidelines

2017 ESC/EACTS Guidelines for the management of valvular heart disease
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
2013 ESCGuidelines on cardiac pacing and cardiac resynchronization therapy

ACC Guidelines

Guideline for the Management of Patients with AF 2014

The Government’s mandate to NHS England for 2017-18

March 2017

The NHS has a unique place at the heart of our society and is – by some distance – the institution that makes us most proud to be British.
It is because of this that the 2017-18 mandate to NHS England goes further than ever before to ensure that we not only deliver the best care and support to today’s NHS patients, but also deliver the reform and renewal needed to sustain the NHS for the future.

Read more